Connecticut, Yale-New Haven Hospital and Yale University
Yale Hematopathology Fellowship
The Departments of Laboratory Medicine and Pathology at Yale-New Haven Hospital (YNHH) and Yale University offer a one-year ACGME-accredited fellowship in diagnostic and investigative hematopathology. The fellow receives comprehensive training in all aspects of diagnostic hematology including: morphologic interpretation of peripheral blood, bone marrow, and lymph nodes. Additional experiences include interpretation of: flow cytometry, cytogenetics, molecular diagnostics, FISH, immunohistochemistry, evaluation of hemoglobinopathies, and special coagulation studies. The fellow will rotate at YNHH, a 1500-bed tertiary care hospital and VA Connecticut Healthcare System, a nearby academic affiliate. Additionally, the fellow is an integral part of a multidisciplinary patient-care team in an NCI-designated Comprehensive Cancer Center with extensive pediatric and adult patient populations and an active stem cell transplantation service. The fellow will participate in several weekly conferences including: adult lymphoma tumor board, adult leukemia conference, pediatric tumor board, coagulation conference, and the VA Connecticut hematopathology rounds. The fellow is encouraged to take advantage of opportunities for basic science, translational and clinical research working with mentors from the departments of Laboratory Medicine and Pathology or with faculty from other basic science and clinical departments at the Yale School of Medicine. In addition, physician-scientist track research opportunities extending investigative training beyond the clinical year are available through a specific institutional research training program in immunohematology.
Candidates must be Board-eligible or Board-certified in AP, CP, AP/CP internal medicine/hematology, or pediatrics/hematology.
Two positions are available.
Support is commensurate with level of postgraduate training.
Completed applications should be made no later than November 1 for the position commencing July 1 of the following year. Please contact Alexa J. Siddon, MD (email@example.com